Article ID Journal Published Year Pages File Type
2879609 The Annals of Thoracic Surgery 2009 5 Pages PDF
Abstract
Despite level 1 evidence, the use of β-blockers, amiodarone, and corticosteroids for prophylaxis of atrial fibrillation among Canadian surgeons remains less than expected. The results of this survey support the need for further clinical trials with robust and clinically relevant outcomes that may further influence surgeons to adopt this practice.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , ,